YFJP improved immune function and boosted CD8+ T cell and CD3+ T cell counts in H22 tumor-bearing mice’s spleen and peripheral blood.YFJP improved immune function and boosted CD8+ T cell and CD3+T cell counts in H22 tumor-bearing mice’s spleen and peripheral blood. Here, CD8A is linked to neoplasm.